Hi Scott, welcome back to OrthoStreams. Can't believe it’s been 20 months since our Q&A. Many readers asked for a follow-up after learning about GEO.
1. Looking back on our first interview which one of your market predictions were most accurate and least accurate?
Thank you, Tiger, always great to get together and talk shop with you. Hindsight is a very powerful thing, right? I feel best about those assertions regarding RFID technology and its ability to dramatically alter how we deliver sterile implants and instruments into ASCs and hospitals. That has been a game changer in the intra-COVID world we now find ourselves in. 20 months ago, I would have talked to you about circumventing the sterile processing department (SPD)…now, we talk about the use of RFID and proprietary software to limit non-essential rep activity.
Where I missed the mark from that initial interview was the proverbial crystal ball. Who could have predicted the impact COVID had on healthcare in the US and its effect on our segment of medical device? Still, COVID presented GEO with the opportunity to shift from primarily being a device manufacturer to being a software company focused on technology and im...
